9 METERS BIOPHARM.
9 METERS BIOPHARM.
Share · US6544052086 · NMTR (LSSI)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - -3,91 % -0,79 % -99,85 %

Company Profile for 9 METERS BIOPHARM. Share

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 2 clinical trial to treat short bowel syndrome. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody for targeted obesity disorders; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. The company is based in Raleigh, North Carolina.

Company Data

Name 9 METERS BIOPHARM.
Company 9 Meters Biopharma, Inc.
Symbol NMTR
Website https://www.9meters.com
Primary Exchange LSSI Lang & Schwarz
ISIN US6544052086
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ms. Bethany Sensenig C.M.A., M.B.A.
Country United States of America
Currency EUR
Employees 0,0 T
Address 8480 Honeycutt Road, 27615 Raleigh
IPO Date 2016-07-11

ID Changes

Date From To
04.05.2020 INNT NMTR

Ticker Symbols

Name Symbol
NASDAQ NMTR

More Shares

Investors who 9 METERS BIOPHARM. hold also have the following shares in their portfolio:
ILIAD 23/30
ILIAD 23/30 Bond
JEFF.GR./CAP 21/31
JEFF.GR./CAP 21/31 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025